首页> 外文OA文献 >Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma

【2h】

Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma

机译：用选择性HDAC6抑制剂ACY-1215和Bortezomib对蛋白质降解途径的双重靶向是淋巴瘤的协同作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jennifer E. Amengual; Paul Johannet; Maximilian Lombardo; Kelly Zullo; Daniela Hoehn; Govind Bhagat; Luigi Scotto; Xavier Jirau-Serrano; Dejan Radeski; Jennifer Heinen; Hongfeng Jiang; Serge Cremers; Yuan Zhang; Simon Jones; Owen A. OConnor;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma [J] . Amengual Jennifer E., Johannet Paul, Lombardo Maximilian, Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第20期

机译：具有选择性HDAC6抑制剂ACY-1215和Bortezomib的蛋白质降解途径的双重靶向在淋巴瘤中具有协同作用。
2. Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma [J] . Amengual Jennifer E., Johannet Paul, Lombardo Maximilian, Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第20期

机译：用选择性HDAC6抑制剂ACY-1215和Bortezomib对蛋白质降解途径的双重靶向是淋巴瘤的协同作用
3. Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway and NUP214-ABL1 fusion protein in human acute lymphoblastic leukemia [J] . Carolina Simioni, Simona Ultimo, Alberto Maria Martelli, Italian Journal of Anatomy and Embryology . 2016,第1期

机译：靶向PI3K / AKT / mTOR途径和NUP214-ABL1融合蛋白的选择性抑制剂在人急性淋巴细胞白血病中的协同作用
4. Imaging and Mapping Individual Target Proteins on Clinical Lymphoma Cells by AFM [C] . Mi Li, Lianqing Liu, Ning Xi, IEEE International Conference on Nano/Molecular Medicine and Engineering . 2015

机译：通过AFM成像和映射临床淋巴瘤细胞上的个体靶蛋白
5. Small-molecule inhibitors targeting survival pathways in B-cell lymphoma. [D] . Arnold, Alan A. 2008

机译：靶向B细胞淋巴瘤生存途径的小分子抑制剂。
6. Dual targeting of protein degradation pathways with the selective HDAC6 inhibitor ACY-1215 and bortezomib is synergistic in lymphoma [O] . Jennifer E. Amengual, Paul Johannet, Maximilian Lombardo, -1

机译：选择性HDAC6抑制剂ACY-1215和硼替佐米对蛋白质降解途径的双重靶向在淋巴瘤中具有协同作用
7. Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia [O] . Carolina Simioni, Simona Ultimo, Alberto M. Martelli, 2016

机译：选择性抑制剂靶向PI3K / AKT / mTOR途径或NUP214-ABL1融合蛋白在人急性淋巴细胞白血病中的协同作用

Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma

著录项

引文网络

相似文献

相关主题

期刊订阅